ALXA Financial Facts

Interest expense: -788K
Total operating expenses: 10.97M
See Full Income Statement

Common stock: 2K
Other accrued expenses: 3.47M
See Full Balance Sheet

Alexza Pharmaceuticals Inc. (ALXA) Earnings

  |   Expand Research on ALXA
Next EPS Date N/A EPS Growth Rate -38.5% *Last Qtr.
Average EPS % Beat Rate -126.9% Revenue Growth Rate +201.8% *Last Qtr.
Average % Move 1-Wk after EPS -5.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/6/13 Q313 -$0.72-$0.54 -$0.18$2.2M$1.98M N/A Details
8/8/13 Q213 -$0.21$0.09 -$0.30$40.84M$14.17M N/A Details
5/14/13 Q113 -$1.31-$0.45 -$0.86$729K$1M N/A Details
3/26/13 Q412 -$0.65N/A N/A $729K$1.88M N/A Details
11/7/12 Q312 -$0.52N/A N/A $729K$1.86M N/A Details
5/10/12 Q112 -$0.04-$0.08 +$0.04$1.88M$1.3M N/A Details
11/30/-1 Q411 -$0.13-$0.12 -$0.01$1.88M$5.8M N/A Details
11/7/11 Q311 -$0.19-$0.14 -$0.05$1.3M$670K N/A Details